These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21163755)

  • 1. Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study.
    Talarowska M; Florkowski A; Zboralski K; Berent D; Wierzbiński P; Gałecki P
    Adv Med Sci; 2010; 55(2):317-27. PubMed ID: 21163755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between working memory effectiveness and depression levels after pharmacological therapy].
    Talarowska M; Zboralski K; Gałecki P
    Psychiatr Pol; 2013; 47(2):255-67. PubMed ID: 23888759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Orzechowska A; Chamielec M; Bartosz G; Kowalczyk E
    Neurosci Lett; 2012 Feb; 510(2):127-31. PubMed ID: 22273980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.
    Gałecki P; Talarowska M; Bobińska K; Kowalczyk E; Gałecka E; Lewiński A
    Neuro Endocrinol Lett; 2013; 34(8):780-6. PubMed ID: 24522026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder.
    Talarowska M; Orzechowska A; Szemraj J; Su KP; Maes M; Gałecki P
    Neuropsychobiology; 2014; 70(1):23-8. PubMed ID: 25171019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Gardner A; Chamielec M; Orzechowska A; Bobińska K; Kowalczyk E
    Mol Biol Rep; 2012 May; 39(5):5359-66. PubMed ID: 22170602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Bobińska K; Kowalczyk E
    Neurochem Res; 2012 Aug; 37(8):1761-7. PubMed ID: 22562440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.
    Galecki P; Talarowska M; Moczulski D; Bobinska K; Opuchlik K; Galecka E; Florkowski A; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(5):436-45. PubMed ID: 23922050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Emotional and language prosody and working memory in patients with depression].
    Talarowska M; Zajączkowska M; Gałecki P
    Pol Merkur Lekarski; 2015 May; 38(227):269-72. PubMed ID: 26039021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Auditory-verbal learning test by Łuria in the examination of psychiatric patients].
    Talarowska M; Florkowski A; Orzechowska A; Zboralski K; Galecki P
    Pol Merkur Lekarski; 2011 Jul; 31(181):41-4. PubMed ID: 21870708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences in cognitive functioning of men and women with a diagnosis of depression].
    Fitas A; Berent D; Talarowska M
    Pol Merkur Lekarski; 2010 Mar; 28(165):199-202. PubMed ID: 20815167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in the euthymic phase of unipolar depression.
    Preiss M; Kucerova H; Lukavsky J; Stepankova H; Sos P; Kawaciukova R
    Psychiatry Res; 2009 Oct; 169(3):235-9. PubMed ID: 19765829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase gene expression and cognitive functions in depression.
    Talarowska M; Szemraj J; Gałecki P
    Adv Med Sci; 2015 Mar; 60(1):1-5. PubMed ID: 25038328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis.
    Mandelli L; Serretti A; Colombo C; Florita M; Santoro A; Rossini D; Zanardi R; Smeraldi E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):598-604. PubMed ID: 16958944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation.
    Klasik A; Krysta K; Krupka-Matuszczyk I
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S18-22. PubMed ID: 21894095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression.
    Göder R; Seeck-Hirschner M; Stingele K; Huchzermeier C; Kropp C; Palaschewski M; Aldenhoff J; Koch J
    J Sleep Res; 2011 Dec; 20(4):544-51. PubMed ID: 21352389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.